WGS - GeneDx Holdings Corp. Class A Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
129.19 16.27 (12.59%) 0.06 (0.04%) 0.12 (0.08%) -0.64 (-0.44%) 4.81 (3.72%) 11.22 (8.36%) --- 4.81 (3.72%)

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Category: SERVICES-HEALTH SERVICES
Market Period: Market

Earnings & Ratios

Basic EPS:
0.38
Diluted EPS:
0.36
Basic P/E:
382.7895
Diluted P/E:
404.0556
RSI(14) 1m:
75.12
VWAP:
145.41
RVol:

Events

Period Kind Movement Occurred At

Related News